Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Thrombosis
29
Clinical Trials
58
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00157651
Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
Completed · Phase 3
NCT00986154
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
Completed · Phase 3
NCT01507051
Switching Study From Warfarin to Rivaroxaban
Completed · Phase 1
📊 Sample Meta-Analyses
CRD42020144798
Effectiveness of external medicine or dressing to prevent infusion-related superficial phlebitis: a systematic review and Bayesian network meta-analysis
Phlebitis is vein endothelial cells were damaged by intravenous injection of str
CRD42017074387
Association between vitamin D Levels and metabolic syndrome: a dose-response meta-analysis
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABE
CRD42022336593
Diagnostic value of thrombin-antithrombin complex for venous thromboembolism: a meta-analysis
VTE refers to the abnormal clotting of blood in the venous lumen, completely or
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Thrombosis
🏥 Names
Disease Name
Thrombosis
Alias Names
Thrombus; Thrombosis
Topic Type
phenotype
🧬 Ontology Classifications
DisGeNET Type
phenotype
UMLS Type
Pathologic Function
MeSH Class
Cardiovascular Diseases
DO Class
disease of anatomical entity
🔗 External References
🔍 Raw view — every non-empty column on this row (27 fields)
name
Thrombosis
alias name
Thrombus; Thrombosis
topic type
phenotype
disgenet disease type
phenotype
umls disease type
Pathologic Function
mesh disease class
Cardiovascular Diseases
do disease class
disease of anatomical entity
umls disease type id
T046
mesh disease class id
C14
do disease class id
DOID:7
herb disease id
HBDIS002939
disgenet id
C0040053
mesh id
D013927
do id
60903
tcmsp disease id
772
🌿 Related Herbs
1 · contains this compound⚗️ Related Ingredients
3 · compounds in this herb🧬 Gene / Protein Targets
3 · genes implicated in this diseaseTHBD
Gene THBD
Thrombin
Coagulation factor Xa
📋 Clinical Trials
12 · subject of clinical studyNCT00157651 Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
→ End Stage Renal Disease|Thrombosis|Bleeding
NCT00986154 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylat
→ Venous Thromboembolism|Deep Vein Thrombosis (DVT)|
NCT01507051 Switching Study From Warfarin to Rivaroxaban
→ Venous Thrombosis
NCT01662908 A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation
→ Deep Vein Thrombosis|Venous Thrombosis
NCT02211326 Genotype-guided Warfarin Individualized Treatment
→ Atrial Fibrillation|Deep Venous Thrombosis
NCT02247414 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenect
→ Cirrhosis|Hypertension|Status;Splenectomy|Venous T
NCT02744092 Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
→ Cancer|Venous Thromboembolism|Deep Vein Thrombosis
NCT02889562 Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillatio
→ Coronary Artery Bypass Grafting|Postoperative Atri
NCT03232398 Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
→ Acute Myocardial Infarction|Left Ventricular Throm
NCT04569279 Rivaroxaban vs. Warfarin in CVT Treatment
→ Cerebral Vein Thrombosis
NCT04645550 Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After
→ Cirrhosis|Splenectomy; Status|Venous Thrombosis|Hy
NCT03413618 Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
→ Deep Vein Thrombosis|Postthrombotic Syndrome
📊 Meta-Analyses
12 · systematic reviewCRD42020144798 Effectiveness of external medicine or dressing to prevent infusion-related super
→ Phlebitis is vein endothelial cells were damaged b
CRD42017074387 Association between vitamin D Levels and metabolic syndrome: a dose-response met
→ A cluster of metabolic risk factors for CARDIOVASC
CRD42022336593 Diagnostic value of thrombin-antithrombin complex for venous thromboembolism: a
→ VTE refers to the abnormal clotting of blood in th
CRD42019139353 Colchicine for prevention of post-lung resection and cardiac procedure atrial fi
→ Current research shows that verification is a drug
CRD42020219131 Efficacy and safety of colchicine treatment on major cardiac adverse events
→ MACE, defined as a composite of cardiovascular dea
CRD42021245699 The Use of Colchicine in percutaneous coronary intervention: a systematic review
→ Coronary artery disease (CAD) Major adverse cardio
CRD42022370864 Colchicine for percutaneous coronary intervention: A meta-analysis.
→ Coronary artery disease (CAD) Major adverse cardio
CRD42020223555 Associated factors of medication adherence employing coumarin derivatives or dir
→ Thrombosis is a mechanism for the development of d
CRD42016043754 Efficacy and safety of bivalirudin versus heparin plus routine use of GP Ilb/III
→ Antithrombotic therapy is essential to prevent adv
CRD42018090050 <div>The safety and effectiveness of enoxaparin and aspirin for extended venous
→ Prevention of deep vein thrombosis and pulmonary e
CRD42020138958 A systematic review of economic evaluation of rivaroxaban versus enoxaparin for
→ Venous thromboembolism (VTE) refers to a blood clo
CRD42020220379 Prophylactic Enoxaparin Dosing by Anti-Xa trough levels in reducing Venous Throm
→ Venous thromboembolism (VTE) poses a significant c
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables